Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease: A Prespecified Secondary Analysis of the ACCELERATE Trial

IMPORTANCE: Although lipoprotein(a) (Lp[a]) is a causal genetic risk factor for atherosclerotic cardiovascular disease, it remains unclear which patients with established atherosclerotic cardiovascular disease stand to benefit the most from Lp(a) lowering. Whether inflammation can modulate Lp(a)-ass...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Cardiol
Main Authors: Puri, Rishi, Nissen, Steven E., Arsenault, Benoit J., St John, Julie, Riesmeyer, Jeffrey S., Ruotolo, Giacomo, McErlean, Ellen, Menon, Venu, Cho, Leslie, Wolski, Kathy, Lincoff, A. Michael, Nicholls, Stephen J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2020
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7344788/
https://ncbi.nlm.nih.gov/pubmed/32639518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2020.2413
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados